These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37116378)

  • 21. Apoptosis-inducing peptide loaded in PLGA nanoparticles induces anti-tumor effects in vivo.
    Priwitaningrum DL; Jentsch J; Bansal R; Rahimian S; Storm G; Hennink WE; Prakash J
    Int J Pharm; 2020 Jul; 585():119535. PubMed ID: 32534162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy.
    Kim B; Shin J; Wu J; Omstead DT; Kiziltepe T; Littlepage LE; Bilgicer B
    J Control Release; 2020 Jun; 322():530-541. PubMed ID: 32276005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
    Li Y; Hou H; Zhang P; Zhang Z
    Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells.
    Liu CW; Lin WJ
    J Drug Target; 2013 Sep; 21(8):776-86. PubMed ID: 23829387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced cellular uptake of near-infrared triggered targeted nanoparticles by cell-penetrating peptide TAT for combined chemo/photothermal/photodynamic therapy.
    Wu H; You C; Chen F; Jiao J; Gao Z; An P; Sun B; Chen R
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109738. PubMed ID: 31349475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functionalized cell nucleus-penetrating peptide combined with doxorubicin for synergistic treatment of glioma.
    Zhang L; Zhang Y; Tai L; Jiang K; Xie C; Li Z; Lin YZ; Wei G; Lu W; Pan W
    Acta Biomater; 2016 Sep; 42():90-101. PubMed ID: 27370905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
    J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-penetrating apoptotic peptide/p53 DNA nanocomplex as adjuvant therapy for drug-resistant breast cancer.
    Wang H; Wang H; Liang J; Jiang Y; Guo Q; Peng H; Xu Q; Huang Y
    Mol Pharm; 2014 Oct; 11(10):3352-60. PubMed ID: 25080334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.
    Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q
    Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
    Yu DH; Lu Q; Xie J; Fang C; Chen HZ
    Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety.
    Zhu L; Wang T; Perche F; Taigind A; Torchilin VP
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17047-52. PubMed ID: 24062440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide-Targeted High-Density Lipoprotein Nanoparticles for Combinatorial Treatment against Metastatic Breast Cancer.
    Jiang C; Wang X; Teng B; Wang Z; Li F; Zhao Y; Guo Y; Zeng Q
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35248-35265. PubMed ID: 34284582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer.
    Zhang C; Zhang F; Han M; Wang X; Du J; Zhang H; Li W
    Sci Rep; 2020 Dec; 10(1):22015. PubMed ID: 33328545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellularly Actuated Quantum Dot-Peptide-Doxorubicin Nanobioconjugates for Controlled Drug Delivery via the Endocytic Pathway.
    Sangtani A; Petryayeva E; Wu M; Susumu K; Oh E; Huston AL; Lasarte-Aragones G; Medintz IL; Algar WR; Delehanty JB
    Bioconjug Chem; 2018 Jan; 29(1):136-148. PubMed ID: 29191007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An injectable, thermosensitive and multicompartment hydrogel for simultaneous encapsulation and independent release of a drug cocktail as an effective combination therapy platform.
    Wang W; Song H; Zhang J; Li P; Li C; Wang C; Kong D; Zhao Q
    J Control Release; 2015 Apr; 203():57-66. PubMed ID: 25683618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circumventing Doxorubicin Resistance Using Elastin-like Polypeptide Biopolymer-Mediated Drug Delivery.
    Dragojevic S; Turner L; Raucher D
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic Antitumor Potency of a Self-Assembling Peptide Hydrogel for the Local Co-delivery of Doxorubicin and Curcumin in the Treatment of Head and Neck Cancer.
    Karavasili C; Andreadis DA; Katsamenis OL; Panteris E; Anastasiadou P; Kakazanis Z; Zoumpourlis V; Markopoulou CK; Koutsopoulos S; Vizirianakis IS; Fatouros DG
    Mol Pharm; 2019 Jun; 16(6):2326-2341. PubMed ID: 31026168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-Penetrating Peptide-Modified Gold Nanoparticles for the Delivery of Doxorubicin to Brain Metastatic Breast Cancer.
    Morshed RA; Muroski ME; Dai Q; Wegscheid ML; Auffinger B; Yu D; Han Y; Zhang L; Wu M; Cheng Y; Lesniak MS
    Mol Pharm; 2016 Jun; 13(6):1843-54. PubMed ID: 27169484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug delivery with nanospherical supramolecular cell penetrating peptide-taxol conjugates containing a high drug loading.
    Tian R; Wang H; Niu R; Ding D
    J Colloid Interface Sci; 2015 Sep; 453():15-20. PubMed ID: 25956129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment.
    Wu B; Lu ST; Zhang LJ; Zhuo RX; Xu HB; Huang SW
    Int J Nanomedicine; 2017; 12():1853-1862. PubMed ID: 28331310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.